Exploring the Brain’s Dark Corners: Parkinson’s and Schizophrenia

Parkinson’s and schizophrenia are an interesting combination. I have tremors and delusions simultaneously. Although, I haven’t had delusions in about a year, so that is good news. Plus, the tremors from the Parkinson’s aren’t that bad. You have to look on the bright side of things even when life has changed your path, to not necessarily where you want to go.

Both are neurological disorders that affect the brain and can have significant impacts on daily life. However, they also differ in many ways.

Parkinson’s disease is a degenerative disorder that affects movement. It is caused by the loss of dopamine-producing cells in the brain, leading to symptoms such as tremors, stiffness, and balance problems. Schizophrenia, on the other hand, is a mental illness characterized by altered perceptions and thoughts, along with difficulty distinguishing between what is real and what is not.

Parkinson’s disease (PD) and schizophrenia are both brain disorders that can occur together, but they have the opposite effects on the brain’s dopamine system.

Parkinson’s disease is a deteriorating disorder that gradually reduces dopamine-producing brain cells. This leads to symptoms like tremors, stiffness, and slower movement. It affects around one million people in the U.S., mostly older adults. While there’s no cure yet, there are treatments to help manage symptoms and improve quality of life.

Psychosis happens when the dopamine system in the brain becomes overactive, leading to symptoms like hallucinations, delusions, and disorganized thinking. It’s often a part of mental health conditions like schizophrenia, bipolar disorder, or major depression, but it can also be triggered by substance use or certain medical issues.

Treating one disorder can put the other at risk. For example, clozapine is used to treat psychosis in PD, but it can also be used to treat schizophrenia. 

  • Adjusting medications for one disorder can worsen symptoms of the other. 
  • PD and schizophrenia share significant genetic overlap.

Early detection of Parkinson’s and schizophrenia allows for treatment before symptoms worsen. Parkinson’s symptoms, like tremors and rigidity, get worse over time, but early treatment helps patients stay independent with therapies and medications. Similarly, early intervention in schizophrenia can prevent severe episodes and support social and work functioning.

Early diagnosis allows treatment to start sooner, improving outcomes. For Parkinson’s, early use of medications like Levodopa or dopamine agonists can manage motor symptoms for years. Similarly, antipsychotics and therapy for schizophrenia work better when started before severe cognitive decline or prolonged psychosis. Early treatment also reduces long-term complications in both conditions.

Untreated symptoms of these disorders can greatly affect lifestyle, relationships, and mental health. Recognizing Parkinson’s or schizophrenia early allows for support systems like counseling, therapy, and community resources to improve quality of life and resilience for patients and their families.

Despite the benefits, identifying these conditions early remains a significant challenge:

Parkinson’s symptoms often start with small, easy-to-miss signs like less facial expression or a slight tremor that can be mistaken for normal aging. In the same way, schizophrenia can show up with vague signs like pulling away from others, mild anxiety, or mood swings that don’t always seem concerning at first.

Both conditions carry a lot of stigma, which can make people hesitant to get help. On top of that, not enough awareness about early warning signs means many delay seeing a doctor and miss out on the chance for early intervention.

Schizophrenia has a bigger stigma than Parkinson’s disease, because it deals with mental health, and you’re labeled unbelievable. I’m so tired of it. It doesn’t have to be that way.

Parkinson’s and schizophrenia share various overlapping symptoms, particularly in cognition, mood, and motor function. This intersection is often rooted in shared neurological pathways, particularly the role of dopamine, which complicates diagnosis and treatment. 

Both conditions can lead to difficulties in memory, focus, and cognitive control:

  • Parkinson’s Disease:Cognitive decline often begins with small changes, like difficulty multitasking, staying organized, or remembering things. In some cases, this can progress to Parkinson’s disease dementia, especially in the later stages.
  • Schizophrenia: Cognitive struggles often show up with psychosis or mood changes. Patients might find it harder to process information quickly or make decisions, even if they’re not experiencing hallucinations or other main symptoms.

Why the overlap? Damage or alteration to the prefrontal cortex and disruptions in dopamine pathways impact cognition in both disorders.

Mood symptoms like depression and anxiety are commonly observed in both conditions:

  • Parkinson’s Disease: Depression and indifference are common and often linked to changes in brain chemistry caused by neural changes. Patients may also seem emotionally withdrawn as they cope with the challenges of their condition.
  • Schizophrenia: Mood changes, like irritability or flat affect, can often go hand in hand with psychosis. Depression is also pretty common as a comorbidity, and it’s often tied to both the condition itself and feelings of social withdrawal.

Why the overlap? Both disorders involve disturbances in chemical messengers, particularly dopamine and serotonin, which regulate mood.

While motor changes are central to Parkinson’s, they also appear in schizophrenia to a lesser extent:

  • Parkinson’s Disease: Symptoms like tremors, rigidity, and bradykinesia (slowness of movement) are hallmark features of the condition. These symptoms progressively worsen over time as dopamine neurons in the substantia nigra degenerate.
  • Schizophrenia: Although less pronounced, some patients experience motor-related issues such as restlessness (akathisia), tremors, or slowed movements. These symptoms are more commonly side effects of antipsychotic medications than inherent to the disease.

Why the overlap? Dysregulation of dopaminergic pathways in regions of the brain controlling movement can contribute to motor symptoms in both conditions.

Difficulty in expressing thoughts can occur in both conditions:

  • Parkinson’s Disease: Speech may become soft, monotone, or slurred, often due to muscular rigidity and slowed movement affecting vocal cords.
  • Schizophrenia: Patients may exhibit disorganized thinking that leads to unclear or shattered speech patterns.

Why the overlap? Issues like neurological damage or chemical imbalances can affect the parts of the brain that handle language and communication.

Medications used for Parkinson’s disease primarily aim to manage symptoms by increasing dopamine levels in the brain or mimicking its action. Here are some common medications and their potential side effects:

  1. Dopamine Agonists (e.g., Pramipexole, Ropinirole):
    • Purpose: Mimic dopamine effects in the brain.
    • Side Effects: Nausea, dizziness, sleepiness, hallucinations, impulse control disorders, and swelling of the legs.
  2. Anticholinergics (e.g., Benztropine, Trihexyphenidyl):
    • Purpose: Help control tremors.
    • Side Effects: Dry mouth, blurred vision, constipation, urinary retention, and confusion.
  3. Amantadine:
    • Purpose: Provides short-term relief of symptoms in early-stage Parkinson’s.
    • Side Effects: Dizziness, insomnia, confusion, and skin discoloration.

In the context of Parkinson’s disease, one of the most common forms of neuromodulation is Deep Brain Stimulation (DBS). DBS involves implanting electrodes in specific areas of the brain, which are connected to a pulse generator implanted in the chest. The device sends electrical impulses to the brain to help regulate abnormal impulses, thereby reducing symptoms such as tremors, rigidity, and bradykinesia (slowness of movement).

Here are some common antipsychotic medications and their potential side effects:

  • First-Generation Antipsychotics (Typical Antipsychotics):
    • Examples: Haloperidol, Chlorpromazine, Fluphenazine.
    • Side Effects: Motor control symptoms like tremors, stiffness, and slowed movements (bradykinesia), along with involuntary movements (tardive dyskinesia), sedation, weight gain, dry mouth, and constipation.
  • Second-Generation Antipsychotics (Atypical Antipsychotics):
    • Examples: Risperidone, Olanzapine, Quetiapine, Aripiprazole, Clozapine.
    • Side Effects: Weight gain, metabolic syndrome (which can increase the risk of diabetes and high cholesterol), sedation, dizziness, and a higher chance of agranulocytosis (a rare but serious drop in white blood cells) are some potential side effects of Clozapine.
  • Long-Acting Injectable Antipsychotics:
    • Examples: Paliperidone palmitate, Aripiprazole lauroxil.
    • Side Effects: Similar to oral antipsychotics, though it may also cause some injection site reactions.

CBT has given me coping strategies to cope with stress and anxiety, and enhance my ability to manage daily challenges. I challenge distorted thoughts and beliefs, which can reduce the intensity and frequency of symptoms like delusions and hallucinations.

It has improved my social interactions and communication skills, which can be beneficial for those experiencing social withdrawal. Also, it helps identify early warning signs of relapse and develops action plans to address them, potentially reducing the risk of future episodes.

It’s not easy to have both Parkinson’s and schizophrenia. I was diagnosed with late-onset schizophrenia about the year 2013. Parkinson’s showed up right before the pandemic. I’m chaotic, and at this stage of Parkinson’s, my body is sore. But I still look at my life as productive.

My journey has taught me the importance of self-care and seeking help when needed. It’s also shown me the power of resilience and finding joy in even the smallest things.
I’ve come a long way since my diagnosis. I’ve also learned to be more open about my mental health journey. The stigma surrounding mental illness can make it difficult to speak up, but by sharing my story, I hope to break down those barriers.

My journey is far from over, but I am grateful for the progress I have made and the lessons I have learned along the way. Through writing and creating content like this, I hope to continue spreading awareness and promoting self-care in the mental health community. Peace and always love. Until next time…

Schizophrenia may increase Parkinson’s disease risk

Role of dopamine in schizophrenia and Parkinson’s disease

Dopamine in Parkinson’s Disease and Schizophrenia

This image has an empty alt attribute; its file name is 29a46ae4a8e7ff3c9bd744238846b334.jpg

Beyond the Shakes: Embracing Peace in Anxious Times(Opens in a new browser tab)

The Stages of Parkinson’s: A Personal Journey of Resilience(Opens in a new browser tab)

Tired of Being Tired: How To Conquer Anxiety-Induced Fatigue(Opens in a new browser tab)

Leave a Reply

About Me

Hi, I’m Cindee, the creator and author behind one voice in the vastness of emotions. I’ve been dealing with depression and schizophrenia for three decades. I’ve been combating anxiety for ten years. Mental illnesses have such a stigma behind them that it gets frustrating. People believe that’s all you are, but you’re so much more. You can strive to be anything you want without limitations. So, be kind.

>

Discover more from One Voice In The Vastness Of Emotions

Subscribe now to keep reading and get access to the full archive.

Continue reading